Reduced inflammation normalizes endometrial receptivity by rebalancing local estrogen and progesterone signaling, which supports implantation
J Appl Anim Res
Growth hormone stimulating peptide therapy, also referred to as growth hormone releasing peptide therapy, is a regimen that involves administering Sermorelin-Ipamorelin-CJC1295 or other growth hormone stimulating prescription into the body to replace the stimulating hormones no longer being sufficiently produced by the body naturally
Tirzepatide also activates GIP receptors, a dual mechanism that clinical trials have shown produces greater average weight reduction in many patients
Methods Study design BARI-STEP is a 68-week double-blind, randomized, placebo-controlled, two-arm, parallel group trial
While the treatment did not significantly alter early inflammatory responses, it enhanced the resolution of inflammation in the sub-chronic phase, as evidenced by reduced microglial activation in the hippocampus (BH-adjusted P =910 -4 ) and whole brain (BH-adjusted P =0.003